Soleno Therapeutics, Inc. (SLNO)

NASDAQ: SLNO · IEX Real-Time Price · USD

39.73

-2.56 (-6.05%)

At close: Jul 2, 2024, 4:00 PM

41.80

+2.07 (5.21%)

After-hours: Jul 2, 2024, 7:06 PM EDT

Soleno Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Selling, General & Admin	13.48	9.84	10.81	8.76	6.93	Upgrade
Research & Development	25.19	15.27	21.45	23.19	16.27	Upgrade
Operating Expenses	38.67	25.11	32.26	31.95	23.2	Upgrade
Operating Income	-38.67	-25.11	-32.26	-31.95	-23.2	Upgrade
Other Expense / Income	0.32	-1.04	-1.35	-7.31	7.58	Upgrade
Pretax Income	-38.99	-24.07	-30.91	-24.64	-30.77	Upgrade
Net Income	-38.99	-24.07	-30.91	-24.64	-30.77	Upgrade
Shares Outstanding (Basic)	16	8	5	4	2	Upgrade
Shares Outstanding (Diluted)	16	8	5	4	2	Upgrade
Shares Change	96.40%	57.90%	27.39%	83.41%	62.77%	Upgrade
EPS (Basic)	-2.36	-2.87	-5.81	-5.85	-13.50	Upgrade
EPS (Diluted)	-2.36	-2.87	-5.81	-5.85	-13.50	Upgrade
Free Cash Flow	-24.94	-20.79	-27.79	-25.23	-17.4	Upgrade
Free Cash Flow Per Share	-1.51	-2.48	-5.23	-6.04	-7.64	Upgrade
EBITDA	-36.71	-21.81	-28.66	-22.4	-28.43	Upgrade
Depreciation & Amortization	2.28	2.25	2.25	2.24	2.34	Upgrade
EBIT	-38.99	-24.07	-30.91	-24.64	-30.77	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).